Dual RNA Processing Roles of Pat1b via Cytoplasmic Lsm1-7 and Nuclear Lsm2-8 Complexes
Caroline Vindry,
Aline Marnef,
Helen Broomhead,
Laure Twyffels,
Sevim Ozgur,
Georg Stoecklin,
Miriam Llorian,
Christopher W. Smith,
Juan Mata,
Dominique Weil,
Nancy Standart
Affiliations
Caroline Vindry
Department of Biochemistry, University of Cambridge, Tennis Court Road, Cambridge CB2 1QW, UK
Aline Marnef
LBCMCP, Centre de Biologie Intégrative (CBI), CNRS, Université de Toulouse UT3, 31062 Toulouse, France
Helen Broomhead
Department of Biochemistry, University of Cambridge, Tennis Court Road, Cambridge CB2 1QW, UK
Laure Twyffels
Center for Microscopy and Molecular Imaging (CMMI), Université libre de Bruxelles (ULB), 6041 Gosselies, Belgium
Sevim Ozgur
Max Planck Institute of Biochemistry, Am Klopferspitz, 82152 Martinsried, Germany
Georg Stoecklin
Division of Biochemistry, Center for Biomedicine and Medical Technology Mannheim, Medical Faculty Mannheim, Heidelberg University, 69047 Heidelberg, Germany; Center for Molecular Biology of Heidelberg University (ZMBH), 69047 Heidelberg, Germany; German Cancer Research Center (DKFZ), DKFZ-ZMBH Alliance, 68167 Mannheim, Germany
Miriam Llorian
Department of Biochemistry, University of Cambridge, Tennis Court Road, Cambridge CB2 1QW, UK
Christopher W. Smith
Department of Biochemistry, University of Cambridge, Tennis Court Road, Cambridge CB2 1QW, UK
Juan Mata
Department of Biochemistry, University of Cambridge, Tennis Court Road, Cambridge CB2 1QW, UK
Dominique Weil
Sorbonne Universités, UPMC Univ Paris 06, CNRS, Biologie du développement Paris Seine - Institut de Biologie Paris Seine (LBD - IBPS), 75005 Paris, France
Nancy Standart
Department of Biochemistry, University of Cambridge, Tennis Court Road, Cambridge CB2 1QW, UK; Corresponding author
Summary: Pat1 RNA-binding proteins, enriched in processing bodies (P bodies), are key players in cytoplasmic 5′ to 3′ mRNA decay, activating decapping of mRNA in complex with the Lsm1-7 heptamer. Using co-immunoprecipitation and immunofluorescence approaches coupled with RNAi, we provide evidence for a nuclear complex of Pat1b with the Lsm2-8 heptamer, which binds to the spliceosomal U6 small nuclear RNA (snRNA). Furthermore, we establish the set of interactions connecting Pat1b/Lsm2-8/U6 snRNA/SART3 and additional U4/U6.U5 tri-small nuclear ribonucleoprotein particle (tri-snRNP) components in Cajal bodies, the site of snRNP biogenesis. RNA sequencing following Pat1b depletion revealed the preferential upregulation of mRNAs normally found in P bodies and enriched in 3′ UTR AU-rich elements. Changes in >180 alternative splicing events were also observed, characterized by skipping of regulated exons with weak donor sites. Our data demonstrate the dual role of a decapping enhancer in pre-mRNA processing as well as in mRNA decay via distinct nuclear and cytoplasmic Lsm complexes. : Pat1 RNA-binding proteins, enriched in P bodies, are key players in cytoplasmic 5′ to 3′ mRNA decay. Vindry et al. demonstrate an additional role of human Pat1b in alternative splicing via the nuclear Lsm complex and identify distinct mRNA targets of Pat1b-dependent splicing and decay regulation. Keywords: Pat1b, PATL1, Lsm, tri-snRNP, SART3, Prp31, P bodies, Cajal bodies, mRNA decay, alternative splicing